Our vision is to end melanoma in our lifetime. It’s big. It’s bold. And the only way to meet this goal is through research. This goal is underpinned by our unique research strategy, which sets out how we invest in the most innovative ideas to accelerate a cure for melanoma patients.
Rather than following the traditional foundation model of granting individual researchers dollars for their individual investigations, AIM seeks to design, manage, and fund paradigm-shifting, global-scale research initiatives that will accelerate the quest for more effective therapies, and, ultimately, find the cure.
